Welcome to our dedicated page for Unusual Machines SEC filings (Ticker: UMAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Unusual Machines, Inc. (UMAC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Unusual Machines is a Nevada corporation with common stock listed on NYSE American under the symbol UMAC, and it files current and periodic reports that describe its operations, governance, and financial position.
Among the most relevant documents for investors are the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which present audited or reviewed financial statements, segment information, and management’s discussion of results. For example, a shareholder letter furnished with a Form 8‑K references a Form 10‑Q filing and provides context on revenue trends, margins, cash position, and capital raises, all of which are detailed in the underlying report.
Unusual Machines also files numerous Current Reports on Form 8-K that disclose material events. Recent 8‑Ks describe items such as purchase orders from Performance Drone Works, a strategic supplier agreement with Dynamic Aerospace Systems, an adjournment and subsequent results of the 2025 Annual Meeting of Stockholders, the lease of a 25,000-square-foot Orlando facility for manufacturing and fulfillment, and a $25 million investment into XTI Aerospace via Series 10 Convertible Preferred Stock. Other 8‑Ks furnish investor presentations and shareholder letters, giving additional insight into strategy and operations.
Proxy materials, including the Definitive Proxy Statement on Schedule 14A, outline board elections, annual meeting procedures, and governance matters. These documents detail how directors are chosen, how stockholders can vote (including virtual meeting logistics), and what proposals are on the ballot.
On Stock Titan, Unusual Machines filings are updated in near real time from EDGAR, and AI-powered summaries help explain the key points of lengthy reports such as 10‑K and 10‑Q filings. Users can quickly understand topics like capital structure changes, lease commitments for new facilities, strategic investments, and outcomes of shareholder votes without reading every page. The filings page also makes it easier to monitor Form 4 insider transaction reports and other ownership-related filings when they are available, giving a clearer view of how executives and major holders interact with UMAC stock.
By using this page, investors can efficiently review Unusual Machines’ regulatory history, from financial performance and manufacturing expansion to governance decisions and strategic partnerships, with AI tools that highlight the most important disclosures in each filing.
UMAC insider Andrew Ross Camden has filed a notice of proposed sale under Rule 144 to sell 50,000 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $544,000. The filing reports that 37,565,276 shares of the issuer’s common stock are outstanding, providing context for the size of the planned sale.
The shares to be sold come from 100,000 restricted stock units acquired from the issuer on 02/03/2025 as compensation, with the payment date listed as 12/12/2025. The notice also discloses that Camden sold 8,750 common shares on 11/20/2025 for gross proceeds of $79,625 during the past three months, as required by Rule 144 aggregation rules.
Unusual Machines, Inc. filed a current report to let investors know it has entered into a strategic supplier agreement with BrooQLy, Inc., which does business as Dynamic Aerospace Systems. Dynamic Aerospace Systems develops next generation unmanned aerial systems for commercial and defense uses, so this relationship is aimed at supporting Unusual Machines’ position in the drone and aerospace market. Details of the agreement itself are provided in a press release dated December 8, 2025, which is included as an exhibit to the report.
Unusual Machines, Inc. reported that its Annual Meeting of Stockholders, which began on December 1, 2025, has been adjourned until December 19, 2025, at 1:00 p.m. ET. The company is using the additional time to solicit more proxy votes so that a quorum can be reached and stockholders can vote on the election of five directors to serve one-year terms until the next annual meeting. This update was communicated through a press release furnished as an exhibit to the current report.
Unusual Machines, Inc. (UMAC)11/20/2025, the officer received 125,000 shares of restricted common stock at a stated price of $0, increasing his beneficial holdings. On the same date, he sold 8,750 shares of common stock at $9.10 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he beneficially owned 306,000 shares of Unusual Machines common stock directly. The restricted stock grant was approved by the issuer’s Compensation Committee and is described as exempt from Section 16(b) under Rule 16b-3.
Unusual Machines, Inc. (UMAC) director Cristina Colon reported a sale of company stock on a Form 4. On 11/20/2025, she sold 8,268 shares of common stock at a weighted average price of $9.0569 per share in multiple transactions within a price range of $9.01 to $9.10. The sale was made under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell shares according to a preset schedule. After this transaction, Colon beneficially owns 52,712 shares of Unusual Machines common stock directly.
Unusual Machines, Inc. (UMAC) reported insider activity by its Chief Financial Officer, Brian Hoff. On 11/20/2025, he received a grant of 125,000 shares of restricted common stock at a stated price of $0, bringing his beneficial holdings higher before a same-day sale. Also on 11/20/2025, he sold 8,750 shares of common stock at $9.10 per share, and after these transactions he beneficially owned 490,475 shares, held directly. The restricted stock grant was approved by the issuer’s Compensation Committee under Rule 16b-3, and the sale was executed under a pre-established Rule 10b-5 trading plan administered by an independent third party.
Unusual Machines, Inc. (UMAC) reported an insider equity award to its Chief Executive Officer and director, Allan Evans. On 11/20/2025, Evans, through 8 Consulting LLC, received a grant of 250,000 shares of restricted common stock at a price of $0 per share, approved by the company’s Compensation Committee under Rule 16b-3.
Following this grant, Evans beneficially owns 1,203,650 shares indirectly through 8 Consulting LLC and 110,789 shares directly of Unusual Machines common stock. Evans is the sole owner of 8 Consulting LLC and holds voting and dispositive control over its holdings.
UMAC$91,000. The table shows 36,875,549 shares of common stock outstanding, providing context for the planned sale size.
The securities to be sold were acquired as restricted stock units from the issuer as compensation. One grant covers 8,334 shares dated 05/19/2025 and another covers 2,308 shares dated 08/19/2025, with payment noted as compensation on 11/20/2025. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
UMAC filed a Form 144 notice indicating that shareholder Andrew Ross Camden may sell up to 8,750 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00. The filing notes that 36,875,549 shares of common stock were outstanding.
Camden previously acquired 100,000 shares of common stock on 02/03/2025 via restricted stock units from the issuer as compensation, with a payment date of 11/20/2025. Over the past three months, he sold 8,750 shares for $85,468.00 on 08/20/2025 and 35,000 shares for $356,187.00 on 08/21/2025.
Brian Joseph Hoff filed a Form 144 notice to sell 8,750 shares of UMAC common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00. The filing notes that UMAC had 36,875,549 shares outstanding of common stock.
The shares to be sold relate to 100,000 common shares acquired from the issuer as restricted stock units on 02/03/2025, with compensation listed as the nature of payment dated 11/20/2025. During the prior three months, Hoff sold 8,750 shares of common stock on 08/20/2025 for gross proceeds of $85,468.00 and 33,750 shares on 08/21/2025 for gross proceeds of $343,465.00.